about
NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseInflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?Chromosomally integrated human herpesvirus 6: questions and answers.Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy.A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.Complete Genome Sequence of Germline Chromosomally Integrated Human Herpesvirus 6A and Analyses Integration Sites Define a New Human Endogenous Virus with Potential to Reactivate as an Emerging Infection.Analyses of germline, chromosomally integrated human herpesvirus 6A and B genomes indicate emergent infection and new inflammatory mediators.Application of an asymmetric helical tube reactor for fast identification of gene transcripts of pathogenic viruses by micro flow-through PCR.Allelic variations in coding regions of the vitamin D receptor gene in dairy cows and potential susceptibility to periparturient hypocalcaemia.Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity.Aggravation of left ventricular dysfunction in patients with biopsy-proven cardiac human herpesvirus A and B infection.Chromosomally integrated human herpesvirus 6 in heart failure: prevalence and treatment.Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.Adaptive immune responses against parvovirus B19 in patients with myocardial disease.Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling.Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy.Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy.Adenine nucleotide translocase 1 expression affects enterovirus infection in human and murine hearts.Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment.Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.miRNA as activity markers in Parvo B19 associated heart disease.Classification of four chemically different amyloid types in routine endomyocardial biopsies by advanced immunohistochemistry.Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.[Quality analysis for treatment of heart muscle diseases].Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging.[Cardiomyopathies II. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy].Viral persistence in the myocardium is associated with progressive cardiac dysfunction.Analysis of endomyocardial biopsies in suspected myocarditis--diagnostic value of left versus right ventricular biopsy.Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect.Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcomeGiant-cell myocarditis in a patient presenting with dilated cardiomyopathy and ventricular tachycardias treated by immunosuppression: A case report
P50
Q33340287-85337E5B-85CD-48F0-B6F5-A88EF31DBC59Q34554896-A0523640-E71D-4C47-9E5B-791D921AABF8Q35629123-9F0ADFA7-17EC-4D08-BBA0-405B15A0E6DAQ36560495-F0484D0B-B4C0-42E8-9703-2C69F1B7B37DQ37952634-9C44729E-A5A6-4C3E-A986-22191EB00D60Q38895571-BD733599-49F5-46AE-841A-0F6CBC69700BQ38900999-3FBB7CE9-4E4A-42DC-B268-92D918E163A2Q39369050-93551261-0599-4688-AA6D-24B9CB798352Q39539275-AC770606-DC75-4832-8D80-EBC9E761770FQ39539286-EA6C2C95-65AE-4202-80DE-D0CB80A3DF7CQ39890849-4B8F6C4D-BED1-40DF-AA82-DE90B5653F82Q40274997-EFB7277E-D30D-4F7B-AFB7-1D4DFB35BBF3Q40323692-82CBFC24-383C-40D7-BD47-4B317B617CFCQ41534534-F233CA8E-74B4-4DAB-BA84-2D9D6B847937Q41666974-C6E3AC0D-3F70-4EC1-8349-C9FC3660E8A3Q41751679-D5709F70-75BD-46E7-B340-1325D9985CB6Q41910453-EAB96342-A5EE-453F-953B-ECAC537E4C1BQ42255247-700E0340-34E1-4240-AC72-54806C08715CQ44462357-5751EF2B-F313-4489-8E67-EAFE00876F73Q45084061-0AAAC076-F296-4199-9F44-4A761FC9C03DQ45750219-CA14C0C2-745F-4F90-9BC3-45610B50D364Q46324535-03EF2329-45B3-4061-A6D5-EAD5E83B9B43Q50537302-4F13447F-7C41-4CBE-97B8-BE3B32A3B892Q51347080-C315467F-6390-43EE-9ACF-31DBFA020D2CQ51846314-C3AE1E87-CE62-471F-9C9A-3A96C444E3B4Q51850947-37F45BA2-86BA-48EC-AB0A-029D68420D6BQ52859324-B8113A29-1482-4479-A9DB-C5EA30CB9F05Q52882724-79951080-681F-4734-AEFD-BED07BBBEF6FQ52887298-61A3F006-1FC7-4311-A0CB-6375E38F3E40Q52893497-89060E28-1E53-48BD-A261-BCBB09090BC7Q52899161-72677B77-D1AF-46E5-8F2F-EFF330920FFDQ52907879-00626250-12D0-4871-B8D3-2167E5D2BE96Q52914361-881648EA-9ECE-4760-97F3-DDBD37928F2BQ52926726-F2840685-7104-4E31-A6EA-57301C7CA45FQ52936185-A4BE7F39-DA95-445E-9376-DEB7AB7ED1F4Q52936642-07D77F44-90CF-4702-BA43-7F9C0A35A206Q53670993-9B40A367-1A96-4B33-9732-96D95D9CD4FBQ54570015-99BDD5C3-2544-46D5-96E8-ABE694C1D590Q56958543-0F0B723F-C335-42B0-9DEF-0B0618F38DB2Q56986080-F4BA9467-679B-4771-8F32-2647599ACBEC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dirk Lassner
@ast
Dirk Lassner
@en
Dirk Lassner
@es
Dirk Lassner
@nl
Dirk Lassner
@sl
type
label
Dirk Lassner
@ast
Dirk Lassner
@en
Dirk Lassner
@es
Dirk Lassner
@nl
Dirk Lassner
@sl
prefLabel
Dirk Lassner
@ast
Dirk Lassner
@en
Dirk Lassner
@es
Dirk Lassner
@nl
Dirk Lassner
@sl
P106
P31
P496
0000-0003-0815-7013